OTCQB:PKTX - Post by User
Post by
lindbeckon Oct 15, 2007 2:28pm
245 Views
Post# 13573778
Peter Hodson...
Peter Hodson...& this man, on BNN, says that cdn. biotech is performing poorly. He would not buy unless Phase 3 results came out. FDA approval. Wants more of a sure thing to minimize risk. I don't blame him. If I could turn back time. Who knows, perhaps the company is seeking out a stronger marketing plan. For now, my finger twitches on the "sell" button, but it's fallen so far, why sell now.